When the core set of symptoms are the same, how can you tell diabetes type 1.5, or LADA, apart from it's famous cousins?
Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot ...
FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix’s investigational intranasal potentiated oxytocin ...
1don MSN
Myth versus fact: What we know about the risks and side effects of the new weight-loss drugs
Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?
FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix's investigational intranasal potentiated oxytocin products in patients with Arginine-Vasopressin Deficien ...
New research reveals that exercise counteracts the mood-damaging effects of a Western-style diet through specific gut and ...
Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...
Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q3 2025 Earnings Call October 22, 2025 4:30 PM EDT Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator ...
Many young professionals feel exhausted, bloated, and experience hair loss despite “normal” blood tests. Dr. Ubaidur Rahman, orthopedic and sports surgeon at Delhis Dr. Ram Manohar Lohia Hospital, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results